Browsing: Bacterial > MRSA
In this infographic we summarize the clinical candidates reported by the WHO – indicating which diseases they are active (or possibly active) against, whether they’re considered innovative and which Phase the trials are currently in.
Researchers have reported that statins could have an antimicrobial effect against Staphylococcus aureus – indicating that statin users may have a decreased risk of S. aureus bloodstream infections outside of hospitals.
Julie Kaiser discusses the findings and implications of a recent study published in PNAS modeling the sequence of events that increases the risk of colonization and infection with multidrug-resistant (MDR) bacteria.
While sepsis is well defined clinically, the molecular immunological mechanisms that underlie the development of sepsis are poorly understood.
DNA sequencing of MRSA could help identify patients who are most at risk of death from the infection – providing a new treatment strategy towards personalized medicine.
New research investigating the evolutionary origins of MRSA has suggested strains may have emerged long before methicillin was used in clinical practice.
In this interview with Patrick Harris, from the University of Queensland, we discuss his role in setting up and co-ordinating the MERINO trial, and his research on the use of genomics in clinical microbiology.
A new study has investigated the effects of commonly used topical antimicrobials on the skin microbiome, discovering that antibiotics have a major and long-lasting effect.